We are live on
!
Find out more
KM
Kalos Management Portfolio holdings
AUM
$46.6M
1-Year Est. Return
11.52%
This Fund
S&P 500
This Quarter
Est. Return
+16.6%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
–
AUM
$234M
AUM Growth
+$9.93M
(+4.4%)
Cap. Flow
-$25.9M
Cap. Flow
% of AUM
-11.05%
Top 10 Holdings %
Top 10 Hldgs %
18.52%
Holding
269
New
36
Increased
60
Reduced
141
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sabra Healthcare REIT
SBRA
|
+$1.83M |
| 2 |
Vanguard Total Corporate Bond ETF
VTC
|
+$1.72M |
| 3 |
Federated Hermes
FHI
|
+$1.53M |
| 4 |
Innoviva
INVA
|
+$1.09M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$7.45M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$4.57M |
| 3 |
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
|
+$2.35M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$2.1M |
| 5 |
Principal Financial Group
PFG
|
+$1.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.59% |
| 2 | Financials | 8.72% |
| 3 | Healthcare | 7.69% |
| 4 | Communication Services | 7.5% |
| 5 | Consumer Discretionary | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
McDonald's
MCD
$192B
| $407K | 0.17% |
1,897
-151
| -7% | -$32.8K |
|
152
W.P. Carey
WPC
$16.8B
| $399K | 0.17% |
5,934
| – | – |
|
153
iShares Future Exponential Technologies ETF
XT
$3.82B
| $391K | 0.17% |
6,841
-292
| -4% | -$15.4K |
|
154
Blue Owl Capital
OBDC
$5.34B
| $389K | 0.17% |
30,733
+2,119
| +7% | +$26.9K |
|
155
Alerian MLP ETF
AMLP
$13B
| $386K | 0.16% |
13,799
-4,556
| -25% | -$109K |
|
156
iShares MSCI EAFE Value ETF
EFV
$28.8B
| $380K | 0.16% |
+7,736
| New | +$341K |
|
157
Sony
SONY
$137B
| $380K | 0.16% |
16,900
-12,750
| -43% | -$222K |
|
158
Walt Disney
DIS
$167B
| $378K | 0.16% |
2,046
-16
| -0.8% | -$2.3K |
|
159
Iovance Biotherapeutics
IOVA
$1.82B
| $378K | 0.16% |
8,150
| – | – |
|
160
VanEck BDC Income ETF
BIZD
$1.59B
| $371K | 0.16% |
25,262
-9,457
| -27% | -$122K |
|
161
Nike
NKE
$61.9B
| $358K | 0.15% |
2,526
-445
| -15% | -$59K |
|
162
NXP Semiconductors
NXPI
$57.8B
| $358K | 0.15% |
1,938
-978
| -34% | -$144K |
|
163
Cambria Global Value ETF
GVAL
$586M
| $356K | 0.15% |
16,669
-2,122
| -11% | -$40K |
|
164
AbbVie
ABBV
$443B
| $344K | 0.15% |
3,247
+98
| +3% | +$9.42K |
|
165
iShares US Treasury Bond ETF
GOVT
$43.6B
| $340K | 0.15% |
12,648
+2,857
| +29% | +$78.8K |
|
166
iShares Core S&P Small-Cap ETF
IJR
$109B
| $339K | 0.14% |
+3,199
| New | +$263K |
|
167
Southern Company
SO
$109B
| $339K | 0.14% |
5,596
-347
| -6% | -$20.9K |
|
168
Bank of America
BAC
$435B
| $337K | 0.14% |
10,617
+485
| +5% | +$13K |
|
169
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $335K | 0.14% |
6,266
+609
| +11% | +$28.6K |
|
170
National Health Investors
NHI
$3.72B
| $332K | 0.14% |
4,821
+1
| +0% | +$64 |
|
171
iShares MSCI South Korea ETF
EWY
$21.9B
| $331K | 0.14% |
3,616
-188
| -5% | -$13.9K |
|
172
Pfizer
PFE
$143B
| $331K | 0.14% |
9,242
-456
| -5% | -$16.7K |
|
173
Walmart Inc
WMT
$885B
| $329K | 0.14% |
6,825
-69
| -1% | -$3.35K |
|
|
BLDP
174
Ballard Power Systems
BLDP
$805M
| $328K | 0.14% |
14,050
-500
| -3% | -$9.21K |
|
175
Mastercard
MA
$502B
| $324K | 0.14% |
955
-14
| -1% | -$4.66K |
|
Similar funds
IM
UCIG
KP
NH
DCM
VCM
FGIM
WGRM
Kalos Management's Q4 2020 Portfolio in Review
As of Q4 2020, Kalos Management held 269 positions worth $234M, up 4.4% from $224M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Kalos Management withdrew a net $25.9M in Q4 2020, closing 17 positions and reducing 141 holdings. Its most notable exit was Principal Financial Group, an estimated $1.91M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Kalos Management opened a new position in Sabra Healthcare REIT worth $2.07M.
- Kalos Management's largest Q4 2020 buy was Sabra Healthcare REIT: 114,870 shares worth $2.07M.
- Kalos Management added most to Vanguard Total Corporate Bond ETF in Q4 2020, an estimated $1.72M increase.
- Kalos Management's biggest Q4 2020 reduction was iShares S&P Mid-Cap 400 Growth ETF, cutting an estimated $7.45M.
- Kalos Management fully exited Principal Financial Group in Q4 2020, selling an estimated $1.91M.
- Kalos Management's ten largest holdings make up 19% of its $234M portfolio in Q4 2020.
- Kalos Management opened 36 new positions and closed 17 in Q4 2020.
- Kalos Management's portfolio value rose 4.4% quarter-over-quarter to $234M.
Based on Kalos Management's 13F filing for Q4 2020, filed 11 Feb 2021.